Intermedin (Adrenomedullin 2) plays a protective role in sepsis by regulating T- and B-cell proliferation and activity
Ontology highlight
ABSTRACT: Sepsis is a life-threatening condition caused by dysregulated host responses to infection. Intermedin (IMD), a calcitonin family peptide, has been shown to protect against sepsis by alleviating vascular leakage and inflammatory responses. Herein, by using transcriptome sequencing (RNA-Seq), we found that IMD-knockout mice exhibited a primary immunosuppression phenotype characterized by a marked decrease in the expression of T- and B-cell function-related genes. This immunosuppression made the IMD-KO mice more vulnerable to pathogenic invasion than normal mice, and even a mild infection killed nearly half of the IMD-KO mice. IMD is likely to directly promote T- and B-cell proliferation through ERK1/2 phosphorylation. In addition, IMD may regulate T-cell differentiation via Ilr7 and Rag1/2, which control T-cell receptor (TCR) recombination, and may regulate B-cell activity via Pax5, which may be the most multifunctional transcription factor for B cells, regulating at least 170 genes that activate genes necessary for B-cell functions. Exogenous supplementation with IMD restored the expression of T/B-cell-related genes and significantly reduced IMD-KO mouse mortality. Our study reveals for the first time that IMD may play an important role in the adaptive immune response by regulating T- and B-cell proliferation and differentiation and provides translational opportunities for the design of immunotherapies for sepsis or other diseases associated with primary immunodeficiency.
ORGANISM(S): Mus musculus
PROVIDER: GSE214090 | GEO | 2022/10/25
REPOSITORIES: GEO
ACCESS DATA